首页> 外文期刊>Clinical proteomics. >The Potentials of Glycomics in Biomarker Discovery
【24h】

The Potentials of Glycomics in Biomarker Discovery

机译:糖蛋白在生物标志物发现中的潜力

获取原文
           

摘要

h2Abstract/h2 h3Introduction/h3 Glycans have unique characteristics that are significantly different from nucleic acids and proteins in terms of biosynthesis, structures, and functions. Moreover, their isomeric nature and the complex linkages between residues have made glycan analysis a challenging task. Disease development and progression are usually associated with alternations in glycosylation on tissue proteins and/or blood proteins. Glycans released from tissue/blood proteins hence provide a valuable source of biomarkers. In this postgenome era, glycomics is an emerging research field. Glycome refers to a repertoire of glycans in a tissue/cell type, while glycomics is the study of glycome. In the past few years, attempts have been made to develop novel methodologies for quantitative glycomic profiling and to identify potential glycobiomarkers. It can be foreseen that glycomics holds the promise for biomarker discovery. This review provides an overview of the unique features of glycans and the historical applications of such features to biomarker discovery. h3Future Prospective/h3 The concept of glycomics and its recent advancement and future prospective in biomarker research are reviewed. Above all, there is no doubt that glycomics is gaining momentum in biomarker research.
机译:>摘要 >简介聚糖具有独特的特性,在生物合成,结构和功能方面与核酸和蛋白质明显不同。此外,它们的异构性质和残基之间的复杂联系使聚糖分析成为一项艰巨的任务。疾病的发展和进展通常与组织蛋白和/或血液蛋白的糖基化改变有关。因此,从组织/血液蛋白中释放出来的聚糖提供了有价值的生物标志物来源。在这个后基因组时代,糖组学是一个新兴的研究领域。糖脂是指组织/细胞类型中的聚糖的全部组成,而糖组学是糖蛋白的研究。在过去的几年中,已经进行了尝试以开发新颖的方法用于定量糖基分析和鉴定潜在的糖生物标志物。可以预见,糖组学有望为生物标志物的发现提供希望。这篇综述概述了聚糖的独特特征以及这些特征在生物标志物发现中的历史应用。 >未来展望综述了糖组学的概念及其在生物标志物研究中的最新进展和未来前景。最重要的是,毫无疑问,糖组学在生物标志物研究中正在获得发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号